• Press Release

BIA announces major initiative with AstraZeneca and new state of the art lifescience innovation campus in Wuxi China

The BioIndustry Association (BIA) has signed a memorandum of understanding with the Wuxi International Life-science Innovation Campus (I-Campus) and AstraZeneca in China. The state-of-the-art campus will enable UK SMES companies to easily explore, partner and engage with China’s rapidly expanding healthcare innovation market. The I-campus will also serve as AstraZeneca’s new China headquarters.

BIA welcomes Chancellor’s commitment to raising R&D investment in Spending Round

Steve Bates OBE, CEO of the BIA said: “We are pleased to see the new administration’s confirmation that the UK is still committed to raising R&D investment and that a new plan to give long-term certainty to the scientific community will be delivered in the Autumn.

The NHS’ rapid adoption of cell and gene therapies will boost availability of innovative therapies for patients says BIA

The UK BioIndustry Association (BIA) has welcomed today’s announcement that the NHS will be providing cell and gene therapies to treat patients with inherited retinal dystrophies.

BIA reaction to Chancellor's announcement on no deal funding

A BIA spokesperson said: "The announced £434 million for medicines and medical products is significant investment, and recognition of the work of DHSC in this area, however we now need the detail of how the money will be spent.

UK Confirms its Leadership Position in Advanced Therapies

Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration New report from Alliance for Regenerative Medicine and UK BioIndustry Association highlights progress in financing and clinical trials 24% of Europe’s ATMP developers headquartered in the UK

BIA warns there is little time to avoid disruption as government announces ‘no-deal’ Brexit planning

Steve Bates OBE, CEO of the BIA responds to the Written Ministerial Statement on EU Exit preparedness published by the Government today.

UK Biotech forges links with new global investors

The UK BioIndustry Association (BIA) is hosting the key movers from the Hong Kong stock exchange in London this week as part of a strategic push to enable global investors to get to know the opportunities in UK biotech.

World leading antibody scientist Dr Jane Osbourn awarded OBE in Queen’s Honours

Dr Jane Osbourn, Vice-President of Research and Development at AstraZeneca and Chair of the UK BioIndustry Association (BIA) has been made an Officer of the Order of the British Empire (OBE) in the Queen’s birthday honours list.

UK Life Sciences Industry welcomes launch of Health Innovation Research Alliance Northern Ireland

Today, 4 June, sees the unveiling of the UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) at a BIO reception in Philadelphia hosted by the UK Department for International Trade, Invest Northern Ireland, the Welsh Government, BIA, AstraZeneca and the British American Business Council of Greater Philadelphia. It will be followed by a formal launch event on 5 June at the Union League of Philadelphia from 08:30-10:00 EST. 

BIO convention is a global opportunity to champion the UK’s successes says BIA

The UK BioIndustry Association (BIA) will be attending the BIO International Convention 2019, which will be hosted in Philadelphia, USA, from 3 – 6 June.